Journal Article DZNE-2026-00035

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Increased transmembrane protein 119 (TMEM119) levels in the cerebrospinal fluid of patients with mild cognitive impairment due to Alzheimer's disease suggest early microglial involvement.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2026
Wiley Hoboken, NJ

Alzheimer's & dementia / Diagnosis, assessment & disease monitoring 18(1), e70240 () [10.1002/dad2.70240]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: We aimed to evaluate the potential of the microglial marker transmembrane protein 119 (TMEM119) in the cerebrospinal fluid (CSF) as a (differential) diagnostic biomarker for neurodegenerative diseases.Following assay validation, we used enzyme-linked immunosorbent assay to measure CSF TMEM119 in 174 patients from six diagnostic groups: Alzheimer's disease (AD, n = 35), amyotrophic lateral sclerosis (ALS, n = 33), cerebral microangiopathy (CM, n = 25), frontotemporal lobar degeneration (FTLD, n = 28), Lewy body diseases (n = 21), and non-neurodegenerative controls (n = 33).CSF TMEM119 levels were elevated in the AD group compared to the control (p = 0.004), CM (p = 0.005), and FTLD (p = 0.023) groups. Levels were higher in both mild cognitive impairment (MCI-AD) and dementia (ADD) subgroups when compared to controls. For the discrimination of AD from controls, the area under the curve (AUC) was 0.78.Our results indicate that CSF TMEM119 may have potential as a biomarker representing microglial involvement in early and later stages of AD.Elevated levels of TMEM119 were observed in the CSF of patients with AD.Increased CSF TMEM119 was seen in MCI-AD patients compared to controls.Elevated levels in MCI-AD underscore early microglial involvement in AD.In the AD group, an association was found between CSF TMEM119 and CSF total tau.CSF TMEM119 may provide valuable information on neuroinflammation.

Keyword(s): Alzheimer's disease ; biomarkers ; cerebrospinal fluid ; microglia ; neuroinflammation

Classification:

Contributing Institute(s):
  1. Clinical Study Center (Ulm) (Clinical Study Center (Ulm))
  2. Neuroepidemiology (AG Zhan)
Research Program(s):
  1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)
  2. 354 - Disease Prevention and Healthy Aging (POF4-354) (POF4-354)

Appears in the scientific report 2026
Database coverage:
Medline ; DOAJ ; Article Processing Charges ; Clarivate Analytics Master Journal List ; DEAL Wiley ; DOAJ Seal ; Emerging Sources Citation Index ; Fees ; IF >= 5 ; JCR ; SCOPUS ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Institute Collections > UL DZNE > UL DZNE-Clinical Study Center (Ulm)
Document types > Articles > Journal Article
Institute Collections > UL DZNE > UL DZNE-AG Zhan
Documents in Process
Public records

 Record created 2026-01-06, last modified 2026-01-06


Restricted:
Download fulltext PDF Download fulltext PDF (PDFA)
External link:
Download fulltextFulltext by Pubmed Central
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)